GlassScriptPhysician profile
Eliza Barnwell
NPI 1568991859
$4,336.31
in general payments reported to CMS, 2019-2025
19 companies · $1,644 in 2025
The $1,644 reported for 2025 was more than what 86% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2021: $391 · 2022: $455 · 2023: $685 · 2024: $724 · 2025: $1,644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,053.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $844.42 | 2022-2025 | Xen Glaucoma Treatment System |
| Johnson & Johnson Surgical Vision, INC. | $574.68 | 2021-2025 | Catalys System, Tecnis Iol, Tecnis Iol |
| Alcon Vision LLC | $318.79 | 2019-2025 | Clareon, Clareon Panoptix Pro, Unity |
| Davol INC. | $298.83 | 2024-2025 | Phasix Mesh |
| Glaukos Corporation | $251.05 | 2019-2023 | |
| Allergan, INC. | $239.31 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $209.47 | 2024-2025 | Xdemvy |
| New World Medical,INC. | $201.42 | 2023-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Bausch & Lomb Americas INC. | $201.24 | 2022-2025 | Envista Mx60 Iol |
| Biotissue Holdings INC. | $160.62 | 2025 | |
| Ivantis, INC | $150.00 | 2021 | |
| Genentech, INC. | $136.97 | 2023 | Vabysmo |
| Harrow Eye, LLC | $124.32 | 2025 | Vevye |
| Axogen | $121.30 | 2023 | Avance Nerve Graft |
| Sun Pharmaceutical Industries INC. | $119.21 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $114.15 | 2024 | Eylea Hd |
| Astellas Pharma US INC | $98.68 | 2024 | Izervay |
| Alexion Pharmaceuticals, INC. | $96.31 | 2019 | |
| Genentech USA, INC. | $75.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eliza Barnwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.